Cystic Fibrosis

December 5, 2016December 5, 2016

NIH $1.7M Grant to Aid Creation of Models That May Personalize Care of Lung Diseases

Cystic Fibrosis, News

A research collaboration between the University of Pittsburgh’s schools of Engineering and Medicine has been awarded a $1.7 million grant by the National Institutes of Health (NIH) to develop new mathematical models that ... Read more

December 2, 2016December 2, 2016

Galapagos Begins Phase 1 Trial of Cystic Fibrosis Corrector in Healthy Volunteers

Cystic Fibrosis, News

Belgium-based Galapagos NV has started its Phase 1 clinical trial evaluating its novel C2 corrector GLPG2737 in healthy volunteers. The drug was developed as part of a triple combination therapy for ... Read more

November 17, 2016November 17, 2016

Multidrug-Resistant Bacterium in Cystic Fibrosis Patients Spreading Globally, Study Finds

Cystic Fibrosis, News

A study led by England’s University of Cambridge and the Wellcome Trust Sanger Institute showed that multidrug-resistant nontuberculous mycobacterium, known to cause serious complications in cystic fibrosis (CF) patients, has spread globally ... Read more

November 15, 2016November 15, 2016

Enterprise Therapeutics Closes on $5 Million in Financing to Develop Mucus-clearing Therapies

Asthma, COPD, Cystic Fibrosis, News

Enterprise Therapeutics has closed on £4 million ($5 million U.S.) in financing to develop and advance its novel mucus-clearing therapies to treat patients with severe lung diseases. Enterprise is pursuing new ... Read more

November 4, 2016November 4, 2016

Preclinical Studies Show Promise for Cystic Fibrosis Therapy in Early Clinical Testing

Cystic Fibrosis, News

SPX-101, an investigational drug for the treatment of cystic fibrosis (CF) being developed by Spyryx Biosciences, has shown to be a safe, stable, and efficient therapy in animal models of the ... Read more

October 26, 2016October 26, 2016

CF Therapy Candidate Resunab Granted Orphan Designation by European Commission

Cystic Fibrosis, News

The European Commission has granted Orphan Designation to Corbus Pharmaceuticals’ Resunab to treat cystic fibrosis (CF) in the European Union. In the U.S., Resunab was granted both orphan drug and fast track designation as ... Read more

October 21, 2016October 21, 2016

NIH Awards Scientists $5.2M for Lung Regeneration Research

Asthma, Cystic Fibrosis, News

Researchers at the University of Pennsyvania School of Medicine, Cincinnati Children’s Hospital and Boston University were awarded a seven-year, $5.2 million grant to study mechanisms that promote lung regeneration. The grant is from ... Read more

October 19, 2016October 19, 2016

Researcher Awarded $13.3M Federal Grant to Test Novel Treatments for Cystic Fibrosis, Severe Asthma

Asthma, Cystic Fibrosis, News

A researcher at Case Western Reserve University (CWRU) in Cleveland, Ohio, was awarded a five-year, $13.3 million federal grant to fund the development and testing of personalized medication combinations tailored to ... Read more

October 13, 2016October 13, 2016

Aradigm Partners to Develop Treatments for Resistant Biofilm Lung Infections

Bronchiectasis, Cystic Fibrosis, News

Aradigm Corporation is collaborating with the University of Sydney in Australia to develop nanotechnologies targeting fungal and bacterial biofilms, a common complication of infections associated with chronic diseases like cystic fibrosis ... Read more

October 6, 2016October 6, 2016

Digital App Ensures Adequate Nutrition and Care for Cystic Fibrosis Patients

Cystic Fibrosis, News

Many people with cystic fibrosis (CF) need help to ensure they’re getting adequate nutrition and the correct amount of enzymes, as well as related reminders. As part of the European MyCyFAPP project, researchers are ... Read more